Rational design matrix materials for organoid development and application in biomedicine
Regenerative Biomaterials · 06.01.2025 · 12
DOI: 10.1093/rb/rbaf038 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Regenerative Biomaterials, online erschienen am 14.05.2025. Verfasst von Yue Huang und 4 weiteren Autor:innen. Beteiligte Einrichtung: CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience…. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 188 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Nova Program.
Abstract (Originalsprache)
Organoids are three-dimensional tissue analogues grown in vitro. Although they are not human organs in the strict sense, they can mimic the structure and function of tissues in vivo to the maximum extent, and have broad application prospects in the fields of organ development, personalized medicine, regenerative medicine, disease modeling, drug screening, gene editing, etc. There is even hope that organoids can replace experimental animals for preclinical testing, which will greatly shorten the cycle of preclinical testing and improve its efficiency. Nowadays, Matrigel remains the predominant substitute for organoid culture systems. At the same time, new extracellular matrix or inspired polymer materials with tunable and optimized biochemical and biophysical properties continue to emerge, which are of great significance for efficient and high-level cultivation of organoids. In this review, we critically evaluate how mechanobiological signaling dynamics at the cell–matrix interface inform the rational engineering of biomimetic extracellular matrices to achieve standardized and phenotypically regulated patient-derived organoid cultures. Then, we systematically classify hydrogel-based matrices encompassing natural, biohybrid, synthetic, protein-engineered and DNA crosslinked matrix systems by their biocompatibility and functional compatibility. Focusing on cancer oncogenesis and progression research, drug development and personalized medicine, we highlight biomimetic hydrogel innovations that recapitulate tumor organoids development. By summarizing the obstacles that hinder the development of organoid hydrogels, we hope to provide an outlook on the future directions for the development of organoid hydrogels and promote the application of organoids in the field of biomedicine.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety & CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, University of Chinese Academy of Sciences, B…
- Department of Occupational and Environmental Health, School of Public Health, Qingdao University, Qingdao 266021, China.
Förderung
- National Key Research and Development Program of China
- National Natural Science Foundation of China
- Beijing Nova Program
Zitieren
APA
Huang, Y., Zhang, X., Zhang, W., Tang, J., & Liu, J. (2025). Rational design matrix materials for organoid development and application in biomedicine. Regenerative Biomaterials, 12. https://doi.org/10.1093/rb/rbaf038
Vancouver
Huang Y, Zhang X, Zhang W, Tang J, Liu J. Rational design matrix materials for organoid development and application in biomedicine. Regenerative Biomaterials. 2025;12. doi:10.1093/rb/rbaf038
BibTeX
@article{Huang2025,
author = {Huang, Yue and Zhang, Xiaoyu and Zhang, Wanjun and Tang, Jinglong and Liu, Jing},
title = {Rational design matrix materials for organoid development and application in biomedicine},
journal = {Regenerative Biomaterials},
year = {2025},
volume = {12},
doi = {10.1093/rb/rbaf038}
}
EUVIMED